Department of Internal Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Eur Rev Med Pharmacol Sci. 2023 Jul;27(13):6176-6181. doi: 10.26355/eurrev_202307_32974.
Tp-e interval and Tp-e/QTc are among the new-generation indicators used for predicting cardiac arrhythmia and ventricular repolarization. In this study, we aimed to evaluate Tp-e and Tp-e/QTc ratios in patients with overt hypothyroidism and subclinical hypothyroid patients.
In this study, a total of 105 patients were included with 35 overt hypothyroidism, 35 subclinical hypothyroidism, and 35 healthy euthyroid patients. The anthropometric measurements, laboratory results, and electrocardiographic data of the patients were measured. The groups were compared in terms of Tp-e interval, Tp-e/QT and Tp-e QT/c ratios.
When the Tp-e interval and Tp-e/QTc values of the patients were compared, a significant difference was found (p<0.001). A positive correlation was found between thyroid stimulating hormone (TSH) with Tp-e interval and Tp-e/QT ratio.
Tp-e interval and Tp-e/QTc duration increased in overt hypothyroidism and subclinical hypothyroidism patients compared to euthyroid patients. We believe that regular use of levothyroxine therapy in overt hypothyroidism patients will decrease cardiac mortality. Cardiac risk factors should be considered to decide on levothyroxine therapy for subclinical hypothyroidism patients.
Tp-e 间期和 Tp-e/QTc 是用于预测心律失常和心室复极的新一代指标之一。本研究旨在评估显性甲状腺功能减退症和亚临床甲状腺功能减退症患者的 Tp-e 和 Tp-e/QTc 比值。
本研究共纳入 105 例患者,其中 35 例为显性甲状腺功能减退症,35 例为亚临床甲状腺功能减退症,35 例为健康甲状腺功能正常患者。测量患者的人体测量学指标、实验室结果和心电图数据。比较各组 Tp-e 间期、Tp-e/QT 和 Tp-e QT/c 比值。
当比较患者的 Tp-e 间期和 Tp-e/QTc 值时,发现有显著差异(p<0.001)。促甲状腺激素(TSH)与 Tp-e 间期和 Tp-e/QT 比值呈正相关。
与甲状腺功能正常患者相比,显性甲状腺功能减退症和亚临床甲状腺功能减退症患者的 Tp-e 间期和 Tp-e/QTc 持续时间增加。我们相信,在显性甲状腺功能减退症患者中定期使用左甲状腺素治疗将降低心脏死亡率。对于亚临床甲状腺功能减退症患者,应考虑心脏危险因素来决定是否进行左甲状腺素治疗。